-
Mashup Score: 32Impact of Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from BMT CTN 1703 - 19 hour(s) ago
Key Points. PTCy based GVHD prophylaxis benefit extends to adults ≥ 70 years with improved GVHD control and improved immunosuppression-free survival.Overal
Source: ashpublications.orgCategories: General Medicine NewsTweet
-
Mashup Score: 85
Although recent studies have demonstrated the efficacy of chimeric antigen receptor T-cell (CAR-T) therapy in relapsed large B-cell lymphoma (LBCL) with MYC rearrangement (R-MYC), the data comparing …
Source: onlinelibrary.wiley.comCategories: General Medicine NewsTweet-
One-size does not fit all: If you ever happen to see a LBCL with excellent chemosensitivity: Auto in those circumstance still reasonable. @FateehaFurqan extends our previous work now to MYC rearranged LBCL @cibmtr #bmtsm https://t.co/EoyIgu47rU https://t.co/tLdQnbXSS4
-
-
Mashup Score: 76Autologous Transplant or CAR‐T as Consolidation Options in MYC Rearranged Large B‐Cell Lymphoma Patients in Remission After Salvage Treatments - 17 day(s) ago
Although recent studies have demonstrated the efficacy of chimeric antigen receptor T-cell (CAR-T) therapy in relapsed large B-cell lymphoma (LBCL) with MYC rearrangement (R-MYC), the data comparing …
Source: onlinelibrary.wiley.comCategories: General Medicine NewsTweet-
One-size does not fit all: If you ever happen to see a LBCL with excellent chemosensitivity: Auto in those circumstance still reasonable. @FateehaFurqan extends our previous work now to MYC rearranged LBCL @cibmtr #bmtsm https://t.co/EoyIgu47rU https://t.co/tLdQnbXSS4
-
-
Mashup Score: 6I'm supporting Audaxity! - 23 day(s) ago
To fund cancer discoveries that cross the finish line for Wisconsinites.
Source: audaxity.donordrive.comCategories: General Medicine NewsTweet-
I'm supporting Audaxity! https://t.co/J3RLa2UYe5 via @DonorDrive I am riding to #EndCancer in Wisconsin. Every $ donated goes to cutting edge cancer research in @MCWCancerCenter
-
-
Mashup Score: 3I'm supporting Audaxity! - 24 day(s) ago
To fund cancer discoveries that cross the finish line for Wisconsinites.
Source: audaxity.donordrive.comCategories: General Medicine NewsTweet-
I'm supporting Audaxity! https://t.co/J3RLa2UYe5 via @DonorDrive I am riding to #EndCancer in Wisconsin. Every $ donated goes to cutting edge cancer research in @MCWCancerCenter
-
-
Mashup Score: 45The potential of antibody-drug conjugates for effective therapy in diffuse large B-cell lymphoma - 4 month(s) ago
Antibody-drug conjugates (ADCs) are a rapidly evolving class of anti-cancer drugs with a significant impact on management of hematological malignancies including diffuse large B-cell lymphoma (DLBC…
Source: www.tandfonline.comCategories: General Medicine News, Hem/OncsTweet-
Current status of ADCs in #lymphoma #DLBCL. Loved developing this invited piece with two lymphoma rising stars @gulrayzahmed & @Taha_CancerDoc @MCWCancerCenter #lymsm https://t.co/65yLN6R6TR
-
-
Mashup Score: 93Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy - 4 month(s) ago
Open access journal of the Ferrata-Storti Foundation, a non-profit organization Open access journal of the Ferrata-Storti Foundation, a non-profit organization Utah Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI Department of Medicine, Weill
Source: haematologica.orgCategories: General Medicine News, Hem/OncsTweet-
Our analysis of CAR-T in #PCNSL, CIBMTR N=24; median age 57; 88% active disease; median piror Rx4; ORR 61%; 2yr OS/PFS 50%/28%; NRM 0; CRS 67%; no G3-4. ICANS 33%; 2 with grade or higher. #lymsm #CART @CatherineLeeMD @mshadman @hemant_murthy et al. https://t.co/RbM02ICClE https://t.co/5t1DS9wuZZ
-
-
Mashup Score: 15Air pollution is associated with increased risk of venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis - 4 month(s) ago
Key Points. Air pollution exposure is common, and may increase risk of developing blood clots.Greater long-term exposure to air pollution (i.e., PM2.5, NOx
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
Air pollution is associated with increased risk of venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis. Recently saw my city #Lahore (Pakistan) and nearby #NewDehli breaking air pollution records https://t.co/211diyidFS
-
-
Mashup Score: 13Air pollution is associated with increased risk of venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis - 5 month(s) ago
Key Points. Air pollution exposure is common, and may increase risk of developing blood clots.Greater long-term exposure to air pollution (i.e., PM2.5, NOx
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
Air pollution is associated with increased risk of venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis. Recently saw my city #Lahore (Pakistan) and nearby #NewDehli breaking air pollution records https://t.co/211diyidFS
-
-
Mashup Score: 53Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study - 5 month(s) ago
Key Points. Glofitamab shows a 47% overall response rate (27% CR, 20% PR) and manageable safety in heavily pretreated r/r LBCL patients.Increased LDH is th
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
Safety and Efficacy of Glofitamab for DLBCL in RW. It works, but like nearly all drugs, works less well in the streets #lymsm https://t.co/5njcmnl7f9
-
Power of PTCy: 1 yr OS of patients 70+ 90%. Work done by @sameem_abedin @sghmd @GvHD_Meade et al. #Gvhd #ptCY https://t.co/IoJZqWXHRE Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from @BMTCTN 1703